USPTO serial 76326915
HEMOTEQ
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 8, 2005
- Examiner
- WELLS, KELLEY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with HEMOTEQ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
52146 Wurseten, DE
52146 Wurseten, DE
52146 Wurseten, DE
WUERSELEN, DE
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ heparin preparations and heparin derivatives combined with organic macromolecular substances with anti-thrombotic and/or anti-coagulative properties for use in coating artificial and natural surfaces for intracorporeal and extracorporeal circulation and for use in coating surgical implants; surgical implants comprising living tissue and organs, namely, heats, heart parts, lungs, arteries, veins, aortas of mammals, especially hearts of pigs, heart valves of pigs and corpse veins; surgical implants comprising living tissue and organs coated with heparin, heparin derivatives and macromolecular agents, namely, hearts, heart valves, lungs, arteries, veins and aortas of mammals * all goods exclusive of the use of antibodies * ] | SECTION 8 - CANCELLED | — |
| 010 | [ surgical implants comprising artificial material, namely, artificial heart valves, hearts, lungs, arteries, veins and aortas; medical instruments and accessories for use with the transfer and handling of blood, namely, tubing, valves, containers, plastic bags, cans, needles, catheters and for use with artificial surgical implants for the cardiovascular system and for extracorporeal circulation; surgical implants comprising artificial material; anti-thrombotic and/or anti-coagulative surgical implants, artificial surfaces, namely, artificial surfaces, namely, artificial heart valves, artificial hearts, artificial lungs, artificial arteries, artificial veins, artificial aortas, tubing, valves, containers, plastic bags, cans, needles, catheters, and accessories for use with the transfer and handling of blood for medical purposes, especially for intracorporeal and extracorporeal circulation; artificial surgical implants coated with heparin, heparin derivatives and macromolecular agents, namely, artificial heart valves, hearts, lungs, arteries, veins and aortas; medical instruments and accessories for use with the transfer and handling of blood coated with heparin, heparin derivatives and macromolecular agents, namely, tubing, valves, containers, plastic bags, cans, needles, catheters and for use with artificial surgical implants for the cardiovascular system and for extracorporeal circulation * all goods exclusive of the use of antibodies * ] | SECTION 8 - CANCELLED | — |
| 040 | Commissioned coating services of artificial surgical implants and of surgical implants comprised of living tissue and organs with biopolymers, especially with heparin, heparin derivatives and anti-thrombotic and/or coagulative macromolecular substances * all coating services exclusive of the use of antibodies * | ACTIVE | — |
| 042 | commissioned research and development services in the fields of surrogates for blood and blood substitutes, blood products, blood-compatible materials and blood-compatible implants; commissioned research and development and consultation services in the fields of artificial surgical implants and of surgical implants comprised of living tissue and organs for the cardiovascular system and for extracorporeal circulation, especially coatings with heparin, heparin derivatives and anti-thrombotic and/or anti-coagulative macromolecular substances; biochemical, pharmaceutical, medical and scientific research services in the fields of surrogates for blood, blood substitutes, blood products, blood-compatible material, blood-compatible implants and blood-compatible parts for the cardiovascular system and for extracorporeal circulation * all research and development services exclusive of the use of antibodies * | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Hemoteq GmbH
- Other trademarks owned by Hemoteq GmbH
- Other trademarks owned by Hemoteq GmbH
- Other trademarks owned by HEMOTEQ AG
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named HEMOTEQ
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 30, 2026 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Jul 30, 2026 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Jul 23, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 23, 2026 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Jul 23, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 23, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 5, 2025 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Feb 5, 2025 | RNL2 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Feb 5, 2025 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Feb 5, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 11, 2024 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Mar 8, 2024 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Dec 12, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 25, 2015 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Apr 25, 2015 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Apr 25, 2015 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Mar 23, 2015 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 6, 2015 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Jul 14, 2011 | CANT | CANCELLATION TERMINATED NO. 999999 | — |
| Jul 14, 2011 | CAND | CANCELLATION DENIED NO. 999999 | — |
| Mar 31, 2011 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Mar 31, 2011 | A7OK | AMENDMENT UNDER SECTION 7 - PROCESSED | — |
| Mar 31, 2011 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 18, 2011 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 4, 2011 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Apr 21, 2010 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 23, 2010 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Feb 25, 2010 | PRAM | POST REGISTRATION ACTION MAILED - SEC. 7 | — |
| Feb 24, 2010 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 23, 2010 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Feb 2, 2009 | PETC | CANCELLATION INSTITUTED NO. 999999 | — |
| Mar 8, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 22, 2004 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Oct 19, 2004 | ALIE | ASSIGNED TO LIE | — |
| Oct 13, 2004 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 13, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 8, 2004 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Sep 24, 2004 | IUAF | USE AMENDMENT FILED | — |
| Sep 24, 2004 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 29, 2004 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 6, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 5, 2004 | EMRV | EMAIL RECEIVED | — |
| Mar 17, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 16, 2004 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 4, 2004 | 44DD | SEC. 44(D) CLAIM DELETED | — |
| Jan 7, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 19, 2003 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Nov 18, 2003 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 29, 2003 | PCRC | PETITION TO DIRECTOR RECEIVED | — |
| Oct 29, 2003 | PAPER RECEIVED | — | |
| Oct 18, 2003 | CFIT | CASE FILE IN TICRS | — |
| Oct 16, 2003 | CFIT | CASE FILE IN TICRS | — |
| Sep 22, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 22, 2003 | PAPER RECEIVED | — | |
| Sep 17, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 19, 2003 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Aug 26, 2002 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jul 3, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 3, 2002 | PAPER RECEIVED | — | |
| Dec 31, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2001 | DOCK | ASSIGNED TO EXAMINER | — |